R Eryl Sharp

R Eryl Sharp, PhD, is an experienced leader in project, program, and portfolio management within the biopharmaceutical and life science sectors. Currently serving as the Executive Director of Global Program Management at Gilead Sciences, R Eryl focuses on inflammation therapeutic areas. They previously held senior roles at Gilead, Pfizer, and Intrexon Corporation, where they demonstrated a strong ability to manage complex projects and lead multi-disciplinary teams. R Eryl obtained their PhD in Biochemistry from the University of Edinburgh, further enhancing their expertise in the field.